Related Experiment Videos
[Mediators and their antagonists in shock therapy]
E Neugebauer1, A Leuchleuthner, A Dietrich
1Biochemische und Experimentelle Abteilung, Universität zu Köln, Bundesrepublik Deutschland.
Langenbecks Archiv Fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft Fur Chirurgie. Kongress
|January 1, 1991
Summary
Identifying causal shock mediators is crucial. Analysis revealed histamine, C5a, beta-endorphin, tumor necrosis factor (TNF), thromboxane B2, platelet-activating factor (PAF), and oxygen free radicals are causally linked to shock symptoms.
Area of Science:
- Biochemistry
- Immunology
- Pharmacology
Context:
- Shock involves over 150 potential mediators.
- Rigorous analysis is needed to identify causal factors.
Purpose:
- To critically evaluate and identify the primary causal mediators of shock.
- To differentiate between associative and causal relationships in shock pathophysiology.
Summary:
- A systematic review using Koch-Dale criteria and decision trees identified histamine, C5a, beta-endorphin, tumor necrosis factor (TNF), thromboxane B2, platelet-activating factor (PAF), and oxygen free radicals as causally associated with shock.
- While experimental data support these mediators, clinical evidence is limited, except for histamine in anaphylactic shock.
Impact:
- Highlights key molecular targets for future shock therapies.
- Suggests combination therapies targeting multiple causal mediators as a promising future direction.
- Emphasizes the need for clinical validation of experimental findings in shock treatment.